{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:11:41Z","timestamp":1790187101695,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s10238-020-00608-5","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T09:03:38Z","timestamp":1579683818000},"page":"207-216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["BAL biomarkers\u2019 panel for differential diagnosis of interstitial lung diseases"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5722","authenticated-orcid":false,"given":"Miriana","family":"d\u2019Alessandro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Carleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cameli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Vietri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Lanzarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Vagaggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piersante","family":"Sestini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"608_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2011.12.002","volume":"33","author":"J Behr","year":"2012","unstructured":"Behr J. Approach to the diagnosis of interstitial lung disease. Clin Chest Med. 2012;33:1\u201310.","journal-title":"Clin Chest Med"},{"key":"608_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0033-8389(05)70334-1","volume":"39","author":"J Collins","year":"2001","unstructured":"Collins J. CT signs and patterns of lung disease. Radiol Clin North Am. 2001;39:1115\u201335.","journal-title":"Radiol Clin North Am"},{"issue":"637\u201349","key":"608_CR3","first-page":"v","volume":"25","author":"KC Meyer","year":"2004","unstructured":"Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25(637\u201349):v.","journal-title":"Clin Chest Med"},{"key":"608_CR4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10238-016-0448-8","volume":"17","author":"Q Zhao","year":"2017","unstructured":"Zhao Q, Yang C, Wang J, et al. Serum level of DNase1l3 in patients with dermatomyositis\/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity. Clin Exp Med. 2017;17:459\u201365.","journal-title":"Clin Exp Med"},{"key":"608_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10238-018-0492-7","volume":"18","author":"V Shobha","year":"2018","unstructured":"Shobha V, Fathima S, Prakash R. Granulomatosis with polyangiitis: clinical course and outcome of 60 patients from a single center in South India. Clin Exp Med. 2018;18:347\u201353.","journal-title":"Clin Exp Med"},{"key":"608_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer KC, Raghu G, Baughman RP, et al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004\u201314.","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"608_CR7","first-page":"360","volume":"2017","author":"ESM Costa","year":"2006","unstructured":"Costa ESM, Rolo R. The role of bronchoalveolar lavage in interstitial lung diseases. Rev Port Pneumol. 2006;2017(23):360\u20132.","journal-title":"Rev Port Pneumol"},{"key":"608_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/15321819.2016.1215998","volume":"38","author":"M Mlika","year":"2017","unstructured":"Mlika M, Kria N, Braham E, et al. The diagnostic importance of the bronchoalveolar lavage in lymphocytic alveolitis. J Immunoass Immunochem. 2017;38:58\u201366.","journal-title":"J Immunoass Immunochem"},{"key":"608_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1067\/mai.2001.119570","volume":"108","author":"AM Patel","year":"2001","unstructured":"Patel AM, Ryu JH, Reed CE. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001;108:661\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"608_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1164\/rccm.200701-093OC","volume":"177","author":"L Barrera","year":"2008","unstructured":"Barrera L, Mendoza F, Zuniga J, et al. Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2008;177:44\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"608_CR11","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1164\/rccm.201611-2201PP","volume":"196","author":"M Vasakova","year":"2017","unstructured":"Vasakova M, Morell F, Walsh S, et al. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017;196:680\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"608_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1164\/ajrccm.187.7.777","volume":"187","author":"WA Wuyts","year":"2013","unstructured":"Wuyts WA, Dooms C, Verleden GM. The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2013;187:777.","journal-title":"Am J Respir Crit Care Med"},{"key":"608_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10238-003-0010-3","volume":"3","author":"JM Fellrath","year":"2003","unstructured":"Fellrath JM, du Bois RM. Idiopathic pulmonary fibrosis\/cryptogenic fibrosing alveolitis. Clin Exp Med. 2003;3:65\u201383.","journal-title":"Clin Exp Med"},{"key":"608_CR14","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/j.lpm.2012.03.019","volume":"41","author":"RP Baughman","year":"2012","unstructured":"Baughman RP, Lower EE, Gibson K. Pulmonary manifestations of sarcoidosis. Presse Med. 2012;41:e289\u2013302.","journal-title":"Presse Med"},{"key":"608_CR15","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153\u201365.","journal-title":"N Engl J Med"},{"key":"608_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0030-1262207","volume":"31","author":"U Costabel","year":"2010","unstructured":"Costabel U, Bonella F, Ohshimo S, Guzman J. Diagnostic modalities in sarcoidosis: BAL, EBUS, and PET. Semin Respir Crit Care Med. 2010;31:404\u20138.","journal-title":"Semin Respir Crit Care Med"},{"key":"608_CR17","doi-asserted-by":"publisher","first-page":"8565423","DOI":"10.1155\/2019\/8565423","volume":"2019","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Bianchi F, Cameli P, et al. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6. Dis Markers. 2019;2019:8565423.","journal-title":"Dis Markers"},{"key":"608_CR18","first-page":"93","volume":"39","author":"C Zhu","year":"2016","unstructured":"Zhu C, Zhao YB, LF Kong, et al. The expression and clinical role of KL-6 in serum and BALF of patients with different diffuse interstitial lung diseases. Zhonghua Jie He He Hu Xi Za Zhi. 2016;39:93\u20137.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"608_CR19","first-page":"313","volume":"32","author":"M Harlander","year":"2016","unstructured":"Harlander M, Salobir B, Zupancic M, Tercelj M. Bronchoalveolar lavage chitotriosidase activity as a biomarker of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;32:313\u20137.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"608_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00296-007-0417-3","volume":"27","author":"E Bargagli","year":"2007","unstructured":"Bargagli E, Rottoli P. Serum chitotriosidase activity in sarcoidosis patients. Rheumatol Int. 2007;27:1187.","journal-title":"Rheumatol Int"},{"key":"608_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1159\/000100555","volume":"74","author":"E Bargagli","year":"2007","unstructured":"Bargagli E, Margollicci M, Nikiforakis N, et al. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration. 2007;74:548\u201352.","journal-title":"Respiration"},{"key":"608_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/00365510701854975","volume":"68","author":"E Bargagli","year":"2008","unstructured":"Bargagli E, Bianchi N, Margollicci M, et al. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity. Scand J Clin Lab Invest. 2008;68:479\u201383.","journal-title":"Scand J Clin Lab Invest"},{"key":"608_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000134009","volume":"76","author":"E Bargagli","year":"2008","unstructured":"Bargagli E, Maggiorelli C, Rottoli P. Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration. 2008;76:234\u20138.","journal-title":"Respiration"},{"key":"608_CR24","first-page":"59","volume":"24","author":"E Bargagli","year":"2007","unstructured":"Bargagli E, Margollicci M, Perrone A, et al. Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2007;24:59\u201364.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"608_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/372190a0","volume":"372","author":"KL Cepek","year":"1994","unstructured":"Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature. 1994;372:190\u20133.","journal-title":"Nature"},{"key":"608_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1046\/j.1365-2249.1999.00894.x","volume":"116","author":"J Lohmeyer","year":"1999","unstructured":"Lohmeyer J, Friedrich J, Grimminger F, et al. Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol. 1999;116:340\u20136.","journal-title":"Clin Exp Immunol"},{"key":"608_CR27","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.clim.2007.11.005","volume":"126","author":"M Heron","year":"2008","unstructured":"Heron M, Slieker WA, Zanen P, et al. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol. 2008;126:338\u201344.","journal-title":"Clin Immunol"},{"key":"608_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.rmed.2012.03.020","volume":"106","author":"PC Mota","year":"2012","unstructured":"Mota PC, Morais A, Palmares C, et al. Diagnostic value of CD103 expression in bronchoalveolar lymphocytes in sarcoidosis. Respir Med. 2012;106:1014\u201320.","journal-title":"Respir Med"},{"key":"608_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00420-014-0947-4","volume":"88","author":"M Couto","year":"2015","unstructured":"Couto M, Palmares C, Beltrao M, et al. Integrin alpha E beta 7 (CD103) expression in bronchoalveolar lymphocytes of patients with hypersensitivity pneumonitis. Int Arch Occup Environ Health. 2015;88:167\u201373.","journal-title":"Int Arch Occup Environ Health"},{"key":"608_CR30","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/labinvest.3780111","volume":"80","author":"MN Kolopp-Sarda","year":"2000","unstructured":"Kolopp-Sarda MN, Kohler C, De March AK, et al. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest. 2000;80:1065\u20139.","journal-title":"Lab Invest"},{"key":"608_CR31","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation. Br Med J. 1961;2:1165\u201372.","journal-title":"Br Med J"},{"issue":"Suppl 5","key":"608_CR32","first-page":"v1","volume":"63","author":"B Bradley","year":"2008","unstructured":"Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society. Thorax. 2008;63(Suppl 5):v1\u201358.","journal-title":"Thorax"},{"key":"608_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","volume":"14","author":"U Costabel","year":"1999","unstructured":"Costabel U, Hunninghake GW. ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American thoracic society. European respiratory society. World association for sarcoidosis and other granulomatous disorders. Eur Respir J. 1999;14:735\u20137.","journal-title":"Eur Respir J"},{"key":"608_CR34","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, et al. An official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3\u201319.","journal-title":"Am J Respir Crit Care Med"},{"key":"608_CR35","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/pmic.200401206","volume":"5","author":"P Rottoli","year":"2005","unstructured":"Rottoli P, Magi B, Cianti R, et al. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics. 2005;5:2612\u20138.","journal-title":"Proteomics"},{"key":"608_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.resinv.2019.02.001","volume":"57","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Bargagli E, Cameli P, et al. Serial KL-6 analysis in patients with idiopathic pulmonary fibrosis treated with nintedanib. Respir Investig. 2019;57:290\u20131.","journal-title":"Respir Investig"},{"issue":"4","key":"608_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","volume":"19","author":"L Bergantini","year":"2019","unstructured":"Bergantini L, Cameli P, d\u2019Alessandro M, et al. NK and NKT-like cells in granulomatous and fibrotic lung diseases. Clin Exp Med. 2019;19(4):487\u201394.","journal-title":"Clin Exp Med"},{"issue":"Suppl 1","key":"608_CR38","first-page":"218","volume":"42","author":"U Costabel","year":"1988","unstructured":"Costabel U. Methods and technic of bronchoalveolar lavage. Prax Klin Pneumol. 1988;42(Suppl 1):218\u201321.","journal-title":"Prax Klin Pneumol"},{"key":"608_CR39","first-page":"103","volume":"42","author":"U Costabel","year":"1988","unstructured":"Costabel U, Bross KJ, Baur R, et al. Cell number, differential cytology and lymphocyte subpopulations of bronchoalveolar lavage under different storage conditions. Prax Klin Pneumol. 1988;42:103\u20135.","journal-title":"Prax Klin Pneumol"},{"key":"608_CR40","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1378\/chest.104.2.352","volume":"104","author":"RH Winterbauer","year":"1993","unstructured":"Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993;104:352\u201361.","journal-title":"Chest"},{"key":"608_CR41","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1378\/chest.104.2.344","volume":"104","author":"RH Winterbauer","year":"1993","unstructured":"Winterbauer RH, Wu R, Springmeyer SC. Fractional analysis of the 120-ml bronchoalveolar lavage Determination of the best specimen for diagnosis of sarcoidosis. Chest. 1993;104:344\u201351.","journal-title":"Chest"},{"key":"608_CR42","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/eji.1830170910","volume":"17","author":"N Cerf-Bensussan","year":"1987","unstructured":"Cerf-Bensussan N, Jarry A, Brousse N, et al. A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes. Eur J Immunol. 1987;17:1279\u201385.","journal-title":"Eur J Immunol"},{"key":"608_CR43","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1159\/000050556","volume":"68","author":"R Kunitake","year":"2001","unstructured":"Kunitake R, Kuwano K, Yoshida K, et al. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Respiration. 2001;68:488\u201395.","journal-title":"Respiration"},{"key":"608_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cca.2009.09.032","volume":"411","author":"R Tanaka","year":"2010","unstructured":"Tanaka R, Takemura M, Sato M, et al. Comparison of chemiluminescence enzyme immunoassay (CLEIA) with ELISA for the determination of anti-cyclic citrullinated peptide antibodies. Clin Chim Acta. 2010;411:22\u20135.","journal-title":"Clin Chim Acta"},{"issue":"Suppl 1","key":"608_CR45","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0954-6111(11)70006-3","volume":"105","author":"M Rijavec","year":"2011","unstructured":"Rijavec M, Volarevic S, Osolnik K, et al. Natural killer T cells in pulmonary disorders. Respir Med. 2011;105(Suppl 1):S20\u20135.","journal-title":"Respir Med"},{"key":"608_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.amepre.2004.10.011","volume":"28","author":"JS Kammerer","year":"2005","unstructured":"Kammerer JS, McNabb SJ, Becerra JE, et al. Tuberculosis transmission in nontraditional settings: a decision-tree approach. Am J Prev Med. 2005;28:201\u20137.","journal-title":"Am J Prev Med"},{"key":"608_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1023\/A:1016409317640","volume":"26","author":"V Podgorelec","year":"2002","unstructured":"Podgorelec V, Kokol P, Stiglic B, Rozman I. Decision trees: an overview and their use in medicine. J Med Syst. 2002;26:445\u201363.","journal-title":"J Med Syst"}],"updated-by":[{"DOI":"10.1007\/s10238-020-00613-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000}}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-020-00608-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-020-00608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T13:13:31Z","timestamp":1650201211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-020-00608-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1007\/s10238-020-00608-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10238-020-00613-8","asserted-by":"object"}]},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article unfortunately contained a mistake. First and last names of the authors were interchanged.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (include name of committee + reference number) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}